Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES)

被引:0
|
作者
Choi, J. [1 ]
Kahwaji, J. [1 ]
Vo, A. [1 ]
Louie, S. [1 ]
Kang, A. [1 ]
Peng, A. [1 ]
Villicana, R. [1 ]
Puliyanda, D. [1 ]
Kim, I. [1 ]
Jordan, S. [1 ]
机构
[1] Cedars Sinai Med Ctr, Comprehens Transplantat Ctr, Los Angeles, CA 90048 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
319
引用
收藏
页码:316 / 316
页数:1
相关论文
共 50 条
  • [1] Long-Term Living Donor Outcomes after Desensitization with IVIG and Rituximab (RIT)
    Najjar, R.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Jordan, S.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 228 - 228
  • [2] Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy
    Gupta, Arjun
    Harris, Samar
    Vernino, Steven
    Naina, Harris V.
    CLINICAL AUTONOMIC RESEARCH, 2015, 25 (04) : 255 - 258
  • [3] Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy
    Arjun Gupta
    Samar Harris
    Steven Vernino
    Harris V. Naina
    Clinical Autonomic Research, 2015, 25 : 255 - 258
  • [4] LONG-TERM ASSESSMENT OF DRUG SAFETY AND EFFICACY
    TURNER, P
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1984, 77 (02) : 93 - 94
  • [5] Safety and efficacy of rituximab-based first line treatment of chronic GVHD
    Solomon, Scott R.
    Sizemore, Connie A.
    Ridgeway, Michelle
    Zhang, Xu
    Brown, Stacey
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem
    Bashey, Asad
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1218 - 1226
  • [6] Safety and efficacy of rituximab-based first line treatment of chronic GVHD
    Scott R. Solomon
    Connie A. Sizemore
    Michelle Ridgeway
    Xu Zhang
    Stacey Brown
    H. Kent Holland
    Lawrence E. Morris
    Melhem Solh
    Asad Bashey
    Bone Marrow Transplantation, 2019, 54 : 1218 - 1226
  • [7] Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability
    Lee, Jiwon
    Park, Eu Gene
    Lee, Munhyang
    Lee, Jeehun
    JOURNAL OF CLINICAL NEUROLOGY, 2017, 13 (01): : 47 - 54
  • [8] HLA Desensitization in Pediatric Heart Transplant Candidates: Efficacy of Rituximab and IVIg
    Schumacher, K. R.
    Schauss, D.
    Schall, C. A.
    Kamoun, M.
    Ramon, D.
    Zamberlan, M. C. G.
    Gajarski, R. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S168 - S168
  • [9] Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
    Vo, Ashley A.
    Petrozzino, Jeffrey
    Yeung, Kai
    Sinha, Aditi
    Kahwaji, Joseph
    Peng, Alice
    Villicana, Rafael
    Mackowiak, John
    Jordan, Stanley C.
    TRANSPLANTATION, 2013, 95 (06) : 852 - 858
  • [10] HLA desensitization in pediatric heart transplant candidates: Efficacy of rituximab and IVIg
    Schumacher, Kurt R.
    Ramon, Daniel S.
    Kamoun, Malek
    Caruthers, Regine
    Gajarski, Robert J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (09): : 1041 - 1042